{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:46:23Z","timestamp":1791636383893,"version":"4.3.4"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hypertrophic cardiomyopathy (HCM) is recognized as the most prevalent form of genetic cardiomyopathy, and recent investigations have shed light on the existence of sex disparities in terms of clinical presentation, disease progression, and outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to systematically review the literature and perform a meta-analysis to comprehensively compare the clinical outcomes between female and male patients with HCM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A thorough search was conducted in databases including PubMed, Embase, Cochrane Library, and Web of Science, encompassing literature from inception until June 2023. The primary endpoints examined were: (1) all-cause mortality; (2) an arrhythmic endpoint comprising sudden cardiac death (SCD), sustained ventricular tachycardia, ventricular fibrillation, or aborted SCD; and (3) a composite endpoint incorporating either (1) or (2), in addition to hospitalization for heart failure or cardiac transplantation. Pooled estimates were derived using a random-effects meta-analysis model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The analysis encompassed a total of 29 observational studies, involving 44,677 patients diagnosed with HCM, of which 16,807 were female. Baseline characteristics revealed that the female group exhibited an advanced age [55.66\u2009\u00b1\u20090.04 years vs. 50.38\u2009\u00b1\u20090.03 years, pooled mean difference (MD)\u2009=\u20090.31, 95% CI: 0.22\u20130.40, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200988.89%], a higher proportion of New York Heart Association class III\/IV patients [pooled odds ratio (OR)\u2009=\u20091.94, 95% CI: 1.55\u20132.43, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200985.92%], and a greater prevalence of left ventricular outflow tract gradient greater than or equal to 30\u2005mmHg (pooled OR\u2009=\u20091.48, 95% CI: 1.27\u20131.73, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200968.88%) compared to the male group. The female group were more likely to have a positive genetic test (pooled OR\u2009=\u20091.27, 95% CI: 1.08\u20131.48, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200942.74%) and to carry the myosin heavy chain beta 7 mutation (pooled OR\u2009=\u20091.26, 95% CI: 1.04\u20131.54, <jats:italic>p<\/jats:italic>\u2009=\u20090.020, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u20090.00%) compared to the male group. Female sex exhibited a significant association with increased risks of all-cause mortality (pooled OR\u2009=\u20091.62, 95% CI: 1.38\u20131.89, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200972.78%) and the composite endpoint (pooled OR\u2009=\u20091.47, 95% CI: 1.20\u20131.79, <jats:italic>p<\/jats:italic>\u2009=\u20090.000, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200984.96%), while no substantial difference was observed in the arrhythmic endpoint (pooled OR\u2009=\u20091.08, 95% CI: 0.87\u20131.34, <jats:italic>p<\/jats:italic>\u2009=\u20090.490, <jats:italic>I<jats:sup>2<\/jats:sup><\/jats:italic>\u2009=\u200955.48%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present findings suggest that female patients with HCM tend to experience poorer clinical outcomes. It is imperative to critically reevaluate disease definitions and enhance awareness to mitigate delays in the diagnosis and treatment of HCM in women, thereby fostering equitable healthcare practices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/<\/jats:ext-link>, PROSPERO (CRD42023431881).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1252266","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:19:59Z","timestamp":1701749999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy"],"prefix":"10.3389","volume":"10","author":[{"given":"Guyue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11897-021-00526-x","article-title":"Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment","volume":"18","author":"Butters","year":"2021","journal-title":"Curr Heart Fail Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo","year":"2010","journal-title":"J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijcard.2021.12.045","article-title":"Sex related differences in exercise performance in patients with hypertrophic cardiomyopathy: hemodynamic insights through non-invasive pressure volume analysis","volume":"351","author":"Argir\u00f2","year":"2022","journal-title":"Int J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jcin.2021.03.066","article-title":"Sex-related differences in outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"14","author":"Veselka","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/2047487319886961","article-title":"Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy","volume":"27","author":"Ghiselli","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjmed.2003.09.020","article-title":"Clinical characteristics of and long-term outcome in Chinese patients with hypertrophic cardiomyopathy","volume":"116","author":"Ho","year":"2004","journal-title":"Am J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.amjms.2020.05.017","article-title":"Influence of gender on clinical characteristics and outcomes in Chinese patients with hypertrophic cardiomyopathy","volume":"360","author":"Huang","year":"2020","journal-title":"Am J Med Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijcard.2020.08.059","article-title":"Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"323","author":"Huurman","year":"2021","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/eurjpc\/zwac078","article-title":"Factors associated with excess female mortality in obstructive hypertrophic cardiomyopathy","volume":"29","author":"Javidgonbadi","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1038\/s41598-021-84335-1","article-title":"Sex differences in the prognosis of patients with hypertrophic cardiomyopathy","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E003062","DOI":"10.1161\/CIRCGEN.120.003062","article-title":"Associations between female sex, sarcomere variants, and clinical outcomes in hypertrophic cardiomyopathy","volume":"14","author":"Lakdawala","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/heartjnl-2022-320852","article-title":"Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"108","author":"Lawin","year":"2022","journal-title":"Heart"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0264580","DOI":"10.1371\/journal.pone.0264580","article-title":"Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ahj.2019.10.004","article-title":"Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy","volume":"219","author":"Lu","year":"2020","journal-title":"Am Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1001\/jamacardio.2019.0084","article-title":"Survival differences in women and men after septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"4","author":"Meghji","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.recesp.2020.01.017","article-title":"The sex gap in hypertrophic cardiomyopathy","volume":"73","author":"S\u00e1 F","year":"2020","journal-title":"Rev Esp Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jtcvs.2021.11.043","article-title":"Sex-based outcomes of surgical myectomy for hypertrophic cardiomyopathy: an analysis from the national readmission database","volume":"166","author":"Osman","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e012041","DOI":"10.1161\/JAHA.119.012041","article-title":"Impact of sex on clinical course and survival in the contemporary treatment era for hypertrophic cardiomyopathy","volume":"8","author":"Rowin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jjcc.2014.07.010","article-title":"Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations","volume":"65","author":"Terauchi","year":"2015","journal-title":"J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.amjcard.2018.08.040","article-title":"Effect of gender and genetic mutations on outcomes in patients with hypertrophic cardiomyopathy","volume":"122","author":"van Velzen","year":"2018","journal-title":"Am J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e102969","DOI":"10.1371\/journal.pone.0102969","article-title":"Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.hlc.2020.04.014","article-title":"Gender disparities in clinical outcome after alcohol septal ablation for hypertrophic obstructive cardiomyopathy in the Chinese Han population: a cohort study","volume":"29","author":"Wang","year":"2020","journal-title":"Heart Lung Circ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pcad.2022.08.002","article-title":"Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy","volume":"74","author":"Hutt","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00380-019-01492-0","article-title":"Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy","volume":"35","author":"Jang","year":"2020","journal-title":"Heart Vessels"},{"key":"B26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/clc.20057","article-title":"Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan - A tertiary center experience","volume":"30","author":"Lee","year":"2007","journal-title":"Clin Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jacc.2011.08.040","article-title":"Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy","volume":"58","author":"Ball","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs. the general European population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1253\/circj.CJ-17-0845","article-title":"Patients\u2019 characteristics and clinical course of hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study","volume":"82","author":"Kubo","year":"2018","journal-title":"Circ J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1136\/heartjnl-2019-315160","article-title":"Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in the asians","volume":"105","author":"Choi","year":"2019","journal-title":"Heart"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur Heart J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000517618","article-title":"Gender-related differences in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Trongtorsak","year":"2021","journal-title":"Pulse (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12872-016-0446-5","article-title":"Gender differences in sudden cardiac death in the young-a nationwide study","volume":"17","author":"Winkel","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"B36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.mayocp.2021.07.022","article-title":"Sex and race disparities in hypertrophic cardiomyopathy: unequal implantable cardioverter-defibrillator use during hospitalization","volume":"97","author":"Patlolla","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e026270","DOI":"10.1161\/JAHA.122.026270","article-title":"Is there a sex difference in the prognosis of hypertrophic cardiomyopathy? A systematic review and meta-analysis","volume":"12","author":"Zhao","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e014448","DOI":"10.1161\/JAHA.119.014448","article-title":"Sex, survival, and cardiomyopathy: differences between men and women with hypertrophic cardiomyopathy","volume":"8","author":"Siontis","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1093\/eurheartj\/ehx639","article-title":"Affairs of the heart: outcomes in men and women with hypertrophic cardiomyopathy","volume":"38","author":"O'Mahony","year":"2017","journal-title":"Eur Heart J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals","volume":"107","author":"Sedaghat-Hamedani","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijcard.2020.12.039","article-title":"Sex-related differences in symptomatic patients with hypertrophic obstructive cardiomyopathy \u2013 time for a new definition?","volume":"328","author":"Batzner","year":"2021","journal-title":"Int J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12471-019-01349-1","article-title":"Effect of body surface area and gender on wall thickness thresholds in hypertrophic cardiomyopathy","volume":"28","author":"Huurman","year":"2020","journal-title":"Neth Heart J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0167-5273(00)00401-0","article-title":"Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy","volume":"77","author":"Dimitrow","year":"2001","journal-title":"Int J Cardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ejrad.2015.04.026","article-title":"Left ventricular remodeling and fibrosis: sex differences and relationship with diastolic function in hypertrophic cardiomyopathy","volume":"84","author":"Chen","year":"2015","journal-title":"Eur J Radiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"947975","DOI":"10.3389\/fcvm.2022.947975","article-title":"Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy","volume":"9","author":"Bi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13293-022-00447-x","article-title":"Sex-related differences in left ventricular remodeling and outcome after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: insights from cardiovascular magnetic resonance imaging","volume":"13","author":"Chen","year":"2022","journal-title":"Biol Sex Differ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000355684","article-title":"Menopause may aggravate symptoms of female apcial hypertrophic cardiomyopathy patients","volume":"126","author":"Yang","year":"2013","journal-title":"Cardiology (Switzerland)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15420\/usc.2016:8:2","article-title":"Do we need a different approach to assess cardiovascular risk in women?","volume":"11","author":"Isiadinso","year":"2017","journal-title":"US Cardiology Review"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/eurjpc\/zwac120","article-title":"Female sex and persistent inequalities in the care of patients with hypertrophic obstructive cardiomyopathy: a call to action","volume":"29","author":"Bhatia","year":"2022","journal-title":"Eur J Prev Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1252266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T04:20:02Z","timestamp":1701750002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1252266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":50,"alternative-id":["10.3389\/fcvm.2023.1252266"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1252266","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"article-number":"1252266"}}